Y-Intercept (HK)’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
+33,542
New +$984K 0.02% 959
2025
Q3
Sell
-10,991
Closed -$157K 1698
2025
Q2
$157K Sell
10,991
-2,409
-18% -$38.1K ﹤0.01% 1492
2025
Q1
$174K Buy
+13,400
New +$202K 0.01% 1074
2024
Q1
Sell
-10,688
Closed -$46.8K 1477
2023
Q4
$46.8K Buy
+10,688
New +$42.8K ﹤0.01% 1164

Other funds holding ETON

Y-Intercept (HK)'s ETON Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 33,542 shares worth $1.21M. The stake represents 0.02% of the portfolio and ranks #959 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ETON as recently as Q2 2025.

Y-Intercept (HK) first reported a position in ETON in Q4 2023 and has held it in 4 quarters since. 9 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Y-Intercept (HK) held 33,542 shares of Eton Pharmaceutcials worth $1.21M as of Q2 2026.
  • Eton Pharmaceutcials was a new Y-Intercept (HK) position in Q2 2026.
  • Eton Pharmaceutcials made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #959 holding.
  • Y-Intercept (HK) first reported a position in Eton Pharmaceutcials in Q4 2023 and has held it in 4 quarters since.
  • 9 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.